The overall point is that higher microRNA expression of these oncogenic factors that directly target PTEN in osteosarcoma has a greater impact on the PI3K/AKT pathway, which ultimately leads to higher malignancy and worse prognosis for patients with osteosarcoma. Here, PTEN is linked to osteosarcoma.